Replacement of Shared Metabolic Analyzer with Agilent Seahorse XF Flex

The National Heart Lung and Blood Institute, which operates under the Department of Health and Human Services National Institutes of Health, has published a Special Notice regarding the replacement of a shared metabolic analyzer with an Agilent Seahorse XF Flex system. This procurement opportunity was posted on September 12, 2025, and falls under the Surgical and Medical Instrument Manufacturing NAICS category (339112) and Laboratory Equipment and Supplies PSC category (6640). The notice does not utilize any set-aside provisions, making it available to all eligible contractors. The federal contract opportunity centers on acquiring specialized laboratory equipment for metabolic analysis capabilities. The government seeks to replace existing shared metabolic analysis equipment with the specifically identified Agilent Seahorse XF Flex platform.

The primary objective of this Special Notice is to procure a replacement metabolic analyzer system to support the National Heart Lung and Blood Institute's research operations and laboratory functions. Contractors interested in this opportunity must respond by the due date of September 17, 2025, providing them with a five-day window from the posting date. The notice does not specify particular set-aside requirements, indicating that all qualified contractors meeting the technical specifications may participate in the procurement process. The acquisition focuses on laboratory equipment essential for metabolic research, suggesting this procurement supports ongoing scientific research initiatives within the National Heart Lung and Blood Institute. The tight timeline between posting and response deadline indicates this may be an urgent replacement need for critical research infrastructure. Given the specific equipment model mentioned, this appears to be a sole-source or limited competition procurement for specialized scientific instrumentation.